Dompe Farmaceutici SPA
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Dompe Farmaceutici SPA
In this edition of the Coronavirus Notebook, an EU consortium uses a supercomputing platform to identify the generic drug raloxifene as a potential COVID-19 treatment, and the World Health Organization proposes a set of principles for distributing a coronavirus vaccine at global level.
Claims circulated on social media that its Cebion supplement could prevent coronavirus has led Italy's Dompé to take legal action.
The funding comes as the Dutch biotech closes in on a potential conditional approval and closure of its acquisition of CytoSen.
The transition period for Australia’s new orphan drug program is coming to an end, and sponsors may need to take action if they want to keep their orphan status - and fee waivers - beyond the end of June.